DE69425033D1 - Verfahren zur Sterilisierung einer menschliches, rekombinantes Serum-albumin enthaltenden pharmazeutischen Zusammensetzung - Google Patents

Verfahren zur Sterilisierung einer menschliches, rekombinantes Serum-albumin enthaltenden pharmazeutischen Zusammensetzung

Info

Publication number
DE69425033D1
DE69425033D1 DE69425033T DE69425033T DE69425033D1 DE 69425033 D1 DE69425033 D1 DE 69425033D1 DE 69425033 T DE69425033 T DE 69425033T DE 69425033 T DE69425033 T DE 69425033T DE 69425033 D1 DE69425033 D1 DE 69425033D1
Authority
DE
Germany
Prior art keywords
sterilization
pharmaceutical composition
composition containing
serum albumin
human recombinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE69425033T
Other languages
English (en)
Other versions
DE69425033T2 (de
Inventor
Tomoshi Ohya
Toyoo Ohda
Shinobu Kuwae
Kenji Tomomitsu
Kaoru Kobayashi
Takao Ohmura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Pharma Corp
Original Assignee
Welfide Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17468634&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69425033(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Welfide Corp filed Critical Welfide Corp
Application granted granted Critical
Publication of DE69425033D1 publication Critical patent/DE69425033D1/de
Publication of DE69425033T2 publication Critical patent/DE69425033T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/04—Heat
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69425033T 1993-10-27 1994-10-26 Verfahren zur Sterilisierung einer menschliches, rekombinantes Serum-albumin enthaltenden pharmazeutischen Zusammensetzung Revoked DE69425033T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5269168A JPH07126182A (ja) 1993-10-27 1993-10-27 組換えヒト血清アルブミン製剤の滅菌方法

Publications (2)

Publication Number Publication Date
DE69425033D1 true DE69425033D1 (de) 2000-08-03
DE69425033T2 DE69425033T2 (de) 2001-03-08

Family

ID=17468634

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69425033T Revoked DE69425033T2 (de) 1993-10-27 1994-10-26 Verfahren zur Sterilisierung einer menschliches, rekombinantes Serum-albumin enthaltenden pharmazeutischen Zusammensetzung

Country Status (8)

Country Link
US (1) US5691451A (de)
EP (1) EP0650736B1 (de)
JP (1) JPH07126182A (de)
KR (1) KR100371045B1 (de)
CA (1) CA2134535C (de)
DE (1) DE69425033T2 (de)
DK (1) DK0650736T3 (de)
ES (1) ES2149230T3 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0770676A3 (de) * 1995-10-23 1999-05-19 Ajinomoto Co., Ltd. Verfahren zur Behandlung von Fermentationsbrühen
EP0995419B1 (de) 1998-10-21 2005-12-21 Nipro Corporation Verfahren zur Herstellung eines Kunststoffbehälters für eine Albuminzubereitung
DE19907257A1 (de) * 1999-02-21 2000-09-14 Bernd Horst Meier Mittel zur Steuerung der Diffusion von Injektionslösungen
US6493867B1 (en) 2000-08-08 2002-12-10 Ball Semiconductor, Inc. Digital photolithography system for making smooth diagonal components
DE10040707A1 (de) * 2000-08-17 2002-03-14 Braun Melsungen Ag Kolloidale Pharmakomodulation injizierter Arzneimittel
JP4798833B2 (ja) 2000-10-24 2011-10-19 一般財団法人化学及血清療法研究所 加熱処理工程を含むヒト血清アルブミンの製造方法
JP4798832B2 (ja) 2000-10-24 2011-10-19 一般財団法人化学及血清療法研究所 ヒト血清アルブミン多量体の除去方法
US6730286B2 (en) * 2001-02-28 2004-05-04 Bracco Diagnostics, Inc. Manufacturing process to control particle size
CA2524246C (en) 2003-04-09 2014-10-14 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Process for producing albumin preparations comprising virus-removing filtration
JP4644604B2 (ja) 2004-01-20 2011-03-02 一般財団法人化学及血清療法研究所 ２価陽イオン存在下加熱処理によるヒト血清アルブミンの製造方法
EP2471557A1 (de) * 2010-12-27 2012-07-04 Università degli Studi di Genova Konjugat von Humanalbumin und 2-(4-Isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecan-1,4,7,10-tetraessigsäure zur Lokalisierung von Radionukliden zu diagnostischen und therapeutischen Zwecken
CN103923211A (zh) * 2014-05-08 2014-07-16 齐智 一种医药级重组人血清白蛋白的纯化方法
ES2524516B1 (es) * 2014-05-29 2015-03-31 Grifols Worldwide Operations Limited Procedimiento de preparación de albúmina humana con nivel de oxígeno disuelto reducido
WO2016108211A1 (en) 2015-01-01 2016-07-07 Navya Biologicals Pvt Ltd Novel method for efficient purification of human serum albumin
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8628104D0 (en) * 1986-11-25 1986-12-31 Connaught Lab Pasteurization of immunoglobin solutions
FR2630115B1 (fr) * 1988-04-14 1994-10-28 Merieux Inst Procede de stabilisation des solutions d'albumine humaine et solution obtenue
JP3554796B2 (ja) * 1988-10-31 2004-08-18 三菱ウェルファーマ株式会社 アルブミン製剤及びその製造方法
JPH0768137B2 (ja) * 1989-06-15 1995-07-26 株式会社ミドリ十字 アルブミン製剤及びその製法
JPH0671434B2 (ja) * 1989-09-18 1994-09-14 株式会社ミドリ十字 ヒト血清アルブミンの製造方法
JP3230091B2 (ja) * 1990-06-25 2001-11-19 ウェルファイド株式会社 ヒト血清アルブミンの着色抑制方法
JPH0671432B2 (ja) * 1991-03-20 1994-09-14 株式会社ミドリ十字 ヒト血清アルブミンの製造方法
JPH07102147B2 (ja) * 1992-03-16 1995-11-08 株式会社ミドリ十字 ヒト血清アルブミンの着色抑制方法

Also Published As

Publication number Publication date
CA2134535C (en) 2004-06-08
DE69425033T2 (de) 2001-03-08
DK0650736T3 (da) 2000-08-28
ES2149230T3 (es) 2000-11-01
US5691451A (en) 1997-11-25
EP0650736B1 (de) 2000-06-28
JPH07126182A (ja) 1995-05-16
KR100371045B1 (ko) 2003-03-19
CA2134535A1 (en) 1995-04-28
EP0650736A1 (de) 1995-05-03
KR950010898A (ko) 1995-05-15

Similar Documents

Publication Publication Date Title
DE69331507D1 (de) Verfahren zur Reinigung von menschlichem, rekombinantem Serumalbumin
DE69532492D1 (de) Verfahren zur Reinigung von rekombinantem menschlichem Serumalbumin
DE69432582D1 (de) System zur Administration von Flüssigkeiten bei mehreren Patienten
DE69425033D1 (de) Verfahren zur Sterilisierung einer menschliches, rekombinantes Serum-albumin enthaltenden pharmazeutischen Zusammensetzung
DE59402624D1 (de) Verfahren zur Herstellung von Cycloolefincopolymeren
NZ294743A (en) A formulation for administering transdermally a protein or polypeptide such as insulin
ES2031806T3 (es) Factor de permeabilidad vascular humano.
DE59501145D1 (de) Verfahren zur Herstellung von Cycloolefincopolymeren
DE59401383D1 (de) Verfahren zur Herstellung von aminosubstituierten Thioethern
DE69005959D1 (de) Verfahren zur Reinigung von menschlichem Serum-Albumin.
DE68920523D1 (de) Verfahren zur Korrektur von Mehr-Byte-Fehlern.
DE69004739D1 (de) Einrichtung zur Vorbereitung medizinischer Lösungen.
DE69129899D1 (de) Verfahren zur Herstellung von D-Alpha-Aminosäuren
DE59400298D1 (de) Verfahren zur Herstellung von Polydimethylsiloxanen
DE69431373D1 (de) Verfahren zur Herstellung von optisch aktiven 2-Amino-1-Phenylethanol-Derivaten
DE69219059D1 (de) Verfahren zur Herstellung von Bisaminomethylcyclohexane
DE69420827D1 (de) Verfahren zur Herstellung von wässrigen Emulsionen zur Umhüllung von festen pharmazeutischen Zusammensetzungen
DE68912895D1 (de) Verfahren zur Herstellung von Tetrafluorethylen-ethylen-Copolymeren.
DE59611383D1 (de) Darreichungsform zur applikation von pharmazeutischen wirkstoffen und hilfsstoffen und verfahren zur herstellung derselben
DE69408919D1 (de) Verfahren zur Herstellung von Polydimethylsiloxanen
DE69220113D1 (de) Verfahren zur Herstellung von menschlichem Serum Albumin
ATE103913T1 (de) Verfahren und zwischenprodukte zur herstellung von oxophthalazinyl-essigsaeuren und deren analogen.
DE69033419D1 (de) Verfahren zur Herstellung von Galacto-Oligosacchariden
DE69329841D1 (de) Verfahren zur Unterdrückung der Koloration von menschlichem Serum-Albumin
DE58904328D1 (de) Verfahren zur desinfektion von medizinischen abformmassen.

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: WELFIDE CORP., OSAKA, JP

8363 Opposition against the patent
8327 Change in the person/name/address of the patent owner

Owner name: MITSUBISHI PHARMA CORP., OSAKA, JP

8331 Complete revocation